RVCL-S affects males and females with equivalent frequency and commonly begins in middle age (35-45 years). It is commonly first noticed as eye symptoms (increased ‘floaters’ or ‘blind spots’). Patients have been identified in a number of countries including the USA, Taiwan, Japan, the Netherlands, Germany, Switzerland, France, Mexico, Italy, Spain, Turkey and Australia. It has not been identified in Africans.
